Literature DB >> 14711858

Acellular pertussis vaccine given by accelerated schedule: response of preterm infants.

M H Slack1, D Schapira, R J Thwaites, C Schapira, J Bamber, M Burrage, J Southern, N Andrews, E Miller.   

Abstract

OBJECTIVE: To describe the immune response of preterm infants to a diphtheria/tetanus/three component acellular pertussis (DTaP) vaccine, under an accelerated schedule, and the effects of steroids on this response. To compare responses with those of term infants.
DESIGN: Prospective observational study.
SETTING: Five Wessex neonatal units; Hertfordshire immunisation clinics. PATIENTS: Infants born at < 32 weeks; term controls.
INTERVENTIONS: DTaP-Haemophilus influenzae type b vaccine given at 2, 3, and 4 months. Blood taken to assess antibody responses to vaccines. MAIN OUTCOME MEASURES: IgG geometric mean concentrations (GMC) to vaccines.
RESULTS: A total of 130 preterm (mean gestational age 29.1 weeks) and 54 term infants were recruited. After the third immunisation, preterm infants had similar GMCs to controls to diphtheria, tetanus, filamentous haemagglutinin (FHA), and pertactin (PRN), but a significantly lower GMC to pertussis toxin (PT). Responses to tetanus and PRN increased with age at the third immunisation, and those to tetanus, FHA, PRN, and PT increased with gestational age at birth. Response to tetanus correlated negatively with the number of doses of antenatal steroids received. There was no association between responses and postnatal steroids.
CONCLUSION: When immunised with a combined acellular pertussis- H influenzae type b vaccine under an accelerated schedule, IgG GMC of preterm infants to PT was reduced. GMCs to tetanus, FHA, PRN, and PT increased with gestational age at birth, and GMCs to tetanus and PRN increased with age at the third immunisation. There is, however, no benefit in delaying immunisation. Anti-tetanus IgG decreased with increasing number of doses of antenatal steroids. There was no effect for postnatal steroids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14711858      PMCID: PMC1721649     

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  8 in total

1.  Response of preterm infants to diphtheria-tetanus-pertussis immunizations.

Authors:  J C Bernbaum; A Daft; R Anolik; J Samuelson; R Barkin; S Douglas; R Polin
Journal:  J Pediatr       Date:  1985-08       Impact factor: 4.406

2.  Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.

Authors:  M H Slack; D Schapira; R J Thwaites; M Burrage; J Southern; N Andrews; R Borrow; D Goldblatt; E Miller
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

3.  Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease.

Authors:  M J Robinson; F Campbell; P Powell; D Sims; C Thornton
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-01       Impact factor: 5.747

4.  Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines.

Authors:  P Olin; F Rasmussen; L Gustafsson; H O Hallander; H Heijbel
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

5.  The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine.

Authors:  G Faldella; R Alessandroni; G M Magini; A Perrone; M R Sabatini; A Vancini; G P Salvioli
Journal:  Vaccine       Date:  1998-10       Impact factor: 3.641

6.  Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae, and polio immunizations.

Authors:  C T D'Angio; W M Maniscalco; M E Pichichero
Journal:  Pediatrics       Date:  1995-07       Impact factor: 7.124

7.  Immunisation of the preterm baby.

Authors:  S Conway; J James; A Balfour; R Smithells
Journal:  J Infect       Date:  1993-09       Impact factor: 6.072

8.  Adverse events and antibody response to accelerated immunisation in term and preterm infants.

Authors:  M E Ramsay; E Miller; L A Ashworth; T J Coleman; M Rush; P A Waight
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

  8 in total
  12 in total

Review 1.  Immunization of preterm infants.

Authors:  Arnaud Gagneur; Didier Pinquier; Caroline Quach
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Immunisation of premature infants.

Authors:  J Bonhoeffer; C-A Siegrist; P T Heath
Journal:  Arch Dis Child       Date:  2006-11       Impact factor: 3.791

Review 3.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

4.  Safety and Immunogenicity of Pneumococcal Conjugate Vaccine in Preterm Infants: A Meta-Analysis.

Authors:  Kai Duan; Jin Guo; Ping Lei
Journal:  Indian J Pediatr       Date:  2016-11-07       Impact factor: 1.967

5.  DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation.

Authors:  M H Slack; S Cade; D Schapira; R J Thwaites; A Crowley-Luke; J Southern; R Borrow; E Miller
Journal:  Arch Dis Child       Date:  2005-04       Impact factor: 3.791

Review 6.  Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability.

Authors:  Carl T D'Angio
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

7.  Association of Routine Infant Vaccinations With Antibody Levels Among Preterm Infants.

Authors:  Elsbeth D M Rouers; Patricia C J Bruijning-Verhagen; Pieter G M van Gageldonk; Josephine A P van Dongen; Elisabeth A M Sanders; Guy A M Berbers
Journal:  JAMA       Date:  2020-09-15       Impact factor: 56.272

Review 8.  Antenatal endogenous and exogenous glucocorticoids and their impact on immune ontogeny and long-term immunity.

Authors:  María Emilia Solano; Megan C Holmes; Paul R Mittelstadt; Karen E Chapman; Eva Tolosa
Journal:  Semin Immunopathol       Date:  2016-07-28       Impact factor: 9.623

Review 9.  Immunization of pregnant women: Future of early infant protection.

Authors:  Azure N Faucette; Michael D Pawlitz; Bo Pei; Fayi Yao; Kang Chen
Journal:  Hum Vaccin Immunother       Date:  2015-09-14       Impact factor: 3.452

10.  Pertussis vaccine: a critique.

Authors:  John B Robbins; Rachel Schneerson; Jerry M Keith; Mark A Miller; Joanna Kubler-Kielb; Birger Trollfors
Journal:  Pediatr Infect Dis J       Date:  2009-03       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.